HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Perry, R. R. Articles by Pass, H. I. Search for Related Content PubMed PubMed Citation Articles by Perry, R. R. Articles by Pass, H. I.

The Annals of Thoracic Surgery, Vol 49, 363-368, Copyright © 1990 by The Society of Thoracic Surgeons

ARTICLES

Survival after surgical resection for high-grade chest wall sarcomas

RR Perry, D Venzon, JA Roth and HI Pass
Surgery Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland 20892.

Indications for chest wall resection of metastatic or locally recurrent sarcoma and for subsequent bony reconstruction are controversial. Twenty-eight patients had chest wall resection for high-grade primary, metastatic, or recurrent sarcoma. In all patients, resection with selective reconstruction of the bony thorax was performed without operative mortality. Since 1980, only patients with four or more ribs resected have had selective bony reconstruction. Follow-up ranged from 8 to 132 months (median follow-up, 42 months). All deaths were related to sarcoma recurrence. The overall actuarial survival rate was 85% at 1 year, 65% at 3 years, and 59% at more than 5 years. The overall actuarial proportion without disease recurrence was 64% at 1 year, 52% at 3 years, and 40% at more than 5 years. There was no significant difference in overall or disease-free survival for patients with primary, metastatic, or recurrent tumors. The most important prognostic factors were positive margins and concomitant pulmonary resection for synchronous lung metastases. These data support aggressive resection to obtain pathologically tumor-free margins for chest wall sarcomas, whether primary, metastatic or recurrent. Reconstruction can be individualized based on the extent of resection.

This article has been cited by other articles:

				M. W. Wouters, A. N. van Geel, L. Nieuwenhuis, H. van Tinteren, C. Verhoef, F. van Coevorden, and H. M. Klomp Outcome After Surgical Resections of Recurrent Chest Wall Sarcomas J. Clin. Oncol., November 1, 2008; 26(31): 5113 - 5118. [Abstract] [Full Text] [PDF]

				C. Lequaglie, P. B. Massone, G. Giudice, and B. Conti Gold Standard for Sternectomies and Plastic Reconstructions After Resections for Primary or Secondary Sternal Neoplasms Ann. Surg. Oncol., June 1, 2002; 9(5): 472 - 479. [Abstract] [Full Text] [PDF]

				G. L. Walsh, B. M. Davis, S. G. Swisher, A. A. Vaporciyan, W. R. Smythe, K. Willis-Merriman, J. A. Roth, and J. B. Putnam Jr A single-institutional, multidisciplinary approach to primary sarcomas involving the chest wall requiring full-thickness resections J. Thorac. Cardiovasc. Surg., January 1, 2001; 121(1): 0048 - 60. [Abstract] [Full Text] [PDF]

				M. S. Allen, D. L. Miller, C. Deschamps, V. F. Trastek, and P. C. Pairolero Chest wall tumors Ann. Thorac. Surg., March 1, 1999; 67(3): 889 - 890. [Full Text] [PDF]

				M. Incarbone, M. Nava, C. Lequaglie, G. Ravasi, and U. Pastorino STERNAL RESECTION FOR PRIMARY OR SECONDARY TUMORS J. Thorac. Cardiovasc. Surg., July 1, 1997; 114(1): 93 - 99. [Abstract] [Full Text]